Buscar
Inventiva SA
IVAAñadir a la lista de seguimiento
3.910USD
+0.220+5.96%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
884.47MCap. mercado
--P/E TTM
Más Datos de Inventiva SA Compañía
Inventiva SA is a France-based company engaged in the biotechnology sector. The Company focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.
Información de Inventiva SA
Símbolo de cotizaciónIVA
Nombre de la empresaInventiva SA
Fecha de salida a bolsaFeb 15, 2017
Director ejecutivoObenshain (Andrew)
Número de empleados- -
Tipo de seguridadDepository Receipt
Fin del año fiscal- -
Dirección50 rue de Dijon
CiudadDAIX
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísFrance
Código postal21121
Teléfono33380447500
Sitio Webhttps://inventivapharma.com/
Símbolo de cotizaciónIVA
Fecha de salida a bolsaFeb 15, 2017
Director ejecutivoObenshain (Andrew)
Ejecutivos de Inventiva SA
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jean Volatier
Mr. Jean Volatier
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nathalie Harroy
Ms. Nathalie Harroy
Director - Human Resources
Director - Human Resources
--
--
Ms. Martine Zimmerman
Ms. Martine Zimmerman
Independent Director
Independent Director
--
--
Dr. Annick Schwebig, M.D.
Dr. Annick Schwebig, M.D.
Independent Director
Independent Director
--
--
Mr. Heinz Maeusli
Mr. Heinz Maeusli
Independent Director
Independent Director
--
--
Ms. Alice Roudot-Ketelers
Ms. Alice Roudot-Ketelers
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Eric Duranson
Mr. Eric Duranson
General Counsel
General Counsel
--
--
Ms. Pascaline Clerc
Ms. Pascaline Clerc
Executive Vice President - Strategy and Corporate Affairs
Executive Vice President - Strategy and Corporate Affairs
--
--
Dr. Mark Pruzanski, M.D.
Dr. Mark Pruzanski, M.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Srinivas (Srini) Akkaraju, M.D., Ph.D.
Dr. Srinivas (Srini) Akkaraju, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jean Volatier
Mr. Jean Volatier
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nathalie Harroy
Ms. Nathalie Harroy
Director - Human Resources
Director - Human Resources
--
--
Ms. Martine Zimmerman
Ms. Martine Zimmerman
Independent Director
Independent Director
--
--
Dr. Annick Schwebig, M.D.
Dr. Annick Schwebig, M.D.
Independent Director
Independent Director
--
--
Mr. Heinz Maeusli
Mr. Heinz Maeusli
Independent Director
Independent Director
--
--
Ms. Alice Roudot-Ketelers
Ms. Alice Roudot-Ketelers
Chief Operating Officer
Chief Operating Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Inventiva SA?
Los cinco principales accionistas de Inventiva SA son: Mr. Jean Volatier
¿Cuántas instituciones poseen acciones de Inventiva SA (IVA)?
A fecha de 2026Q1, 63 instituciones poseen acciones de Inventiva SA, con un valor de mercado combinado de aproximadamente 49.29M, lo que representa el 25.51% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 35581870.00.